bilaterals.org logo
bilaterals.org logo

medicines


Tonga’s WTO accession has TRIPS+ linkage
Tonga acceded to the WTO yesterday and one of the conditions of it being allowed to join the WTO was to have TRIPS+ linkage of patent status and data exclusivity.
US economic and security interests enhanced by moral trade agreements
The chairman of the bishops’ International Policy Committee Monday offered a Catholic perspective on a pending free trade agreement, suggesting that the United States and several Andean nations could simultaneously promote human dignity and fair and sustainable development.
FTA ’to bar cheap Aids drugs’
Aids patients are unlikely to gain access to cheaper drugs after the free trade agreement between Thailand and the United States is signed, as the planned Thai-US FTA is likely to protect only American patented drugs.
Peru’s acceptance of IP terms led to trade pact with US
An agreement by Peru to accept US demands on protecting intellectual property rights, including protections for pharmaceutical test data found in other US free trade agreements, paved the way for a final deal on a US-Peru FTA.
US, Andean nations narrow differences on IP in trade talks
Andean countries in late November narrowed differences with the United States over intellectual property protections in negotiations over a US-Andean bilateral free trade agreement, but divisions over market access for agriculture have likely delayed a final agreement until next year, at least for Colombia and Ecuador.
Peru close to sign FTA with US
The proposed free trade pact with the US has caused big demonstrations in Peru due to the farmers of sugar cane, rice, corn, potatoes and cotton fear that US agricultural subsidies will make it impossible for them to compete.
Dangerous liaison
Under the guise of freeing trade, bilateral trade agreements (BTAs) are being used as a tool to further an absolute top-down Northern agenda, at the victimization of the poor and marginalized groups and communities of the South.
Disagreement over data protection holding up US-Andean FTA
Ecuador’s opposition to US demands on access to test data for clinical drug trials has emerged as a primary obstacle in the ongoing free trade agreement (FTA) talks between the US and a group of three Andean countries.
EIU: Andean FTA talks near conclusion
An Economist Intelligence Unit briefing paper
US responsive to Thai concerns
US congressmen have pledged to accommodate Thailand’s concerns about drug prices and freer mobility for Thais into the United States once the two countries conclude their free trade area (FTA) agreement.
US, three S. American nations begin talks
The United States began a new round of negotiations Monday with Peru, Ecuador and Colombia for a proposed free-trade agreement aimed at giving the three South American nations tariff-free access to US markets.
Govt urged to seek consensus before signing FTA with US
The Thai government should seek a consensus from the public before signing a free trade area (FTA) agreement with the United States, according to a leading academic.
Free trade agreement: impact in Thailand
This booklet by FTA Watch is aimed at disseminating information to international civil society for the purpose of sharing the analyses and experience of the FTA struggle in Thailand.
Big Pharma’s free ride
Pharmaceutical companies are using free-trade deals like CAFTA to eliminate global competition — and deny poor patients access to cheaper generic drugs.
’US-Peru FTA could deprive millions of essential drugs’
With many Peruvians already dying from treatable illness due to difficulties in accessing drugs, a UN human rights expert has expressed "deep concern" that an eventual US-Peru Free Trade Agreement (FTA) could deprive millions more of essential drugs made unaffordable by stronger protection of patents.
UN expert concerned US-Peru free trade accord could deprive poor of medicine
With many Peruvians already dying from treatable illness due to difficulties in accessing drugs, a United Nations human rights expert today voiced deep concern that an eventual United States-Peru Free Trade Agreement (FTA) could deprive millions more of essential drugs made unaffordable by stronger protection of patents.
Exporting prices: Drug makers’ trade group makes the industry’s priorities US trade policy
The Pharmaceutical Research and Manufacturers of America, which represents 67 parent companies and subsidiaries that develop and make prescription and over-the-counter drugs, listed contacts with the government’s top officials overseeing international trade agreements on more lobbying reports than it did for contacts with the Food and Drug Administration, which directly oversees the industry’s products.
Thailand-US: AIDS drugs take centre-stage at trade talks
After tiptoeing around the issue for months, Thailand’s trade negotiators will have to finally reveal where they stand on the life-or-death question of producing cheap, generic anti-AIDS drugs.
TRIPS, bilateralism, multilateralism & implications for developing countries: Jordan’s drug sector
Looking at the experience of Jordan’s pharmaceutical sector, this paper shows that the expected benefits from bilateral agreements between developed and developing countries have been largely overestimated while the costs underestimated.
Thai AIDS activists fear losing cheap drugs in free trade talks with Japan, US
As Thailand prepares for new rounds of free trade talks with Japan and the United States, AIDS activists are voicing increasing concern that patients here could lose access to cheap, life-prolonging drugs.